318 related articles for article (PubMed ID: 15074003)
1. Tandem bone marrow transplantation in multiple myeloma.
Chng WJ
N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
[No Abstract] [Full Text] [Related]
2. The role of transplant in multiple myeloma.
Barlogie B
Clin Adv Hematol Oncol; 2005 Aug; 3(8):604-6. PubMed ID: 16167043
[No Abstract] [Full Text] [Related]
3. [Value of hematopoietic stem cell autotransplantation in the treatment of multiple myeloma: initial experience at the National Bone Marrow Transplantation Center and review of the literature].
Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
Tunis Med; 2000 Oct; 78(10):548-56. PubMed ID: 11190737
[TBL] [Abstract][Full Text] [Related]
4. Tandem bone marrow transplantation in multiple myeloma.
Murashige N; Kishi Y
N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15070801
[No Abstract] [Full Text] [Related]
5. Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Nooka AK; Harvey RD; Langston A; Collins H; Lonial S; Kaufman JL
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e59-63. PubMed ID: 24378319
[No Abstract] [Full Text] [Related]
6. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiation.
Hunter HM; Peggs K; Powles R; Rahemtulla A; Mahendra P; Cavenagh J; Littlewood T; Potter M; Hunter A; Pagliuca A; Williams CD; Cook G; Towlson K; Marks David I; Russell NH;
Br J Haematol; 2005 Feb; 128(4):496-502. PubMed ID: 15686458
[TBL] [Abstract][Full Text] [Related]
7. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S
Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.
Regelink JC; van Roessel CH; van Galen KP; Ossenkoppele GJ; Huijgens PC; Zweegman S
J Clin Oncol; 2010 Dec; 28(35):e741-3; author reply e744-5. PubMed ID: 21060027
[No Abstract] [Full Text] [Related]
9. Autologous hematopoietic stem-cell transplantation for multiple myeloma.
Harousseau JL; Moreau P
N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803
[No Abstract] [Full Text] [Related]
10. Allografting or autografting for myeloma.
Rajkumar SV; Kyle RA
N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600891
[No Abstract] [Full Text] [Related]
11. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
[TBL] [Abstract][Full Text] [Related]
12. Allografting or autografting for myeloma.
Moreau P; Harousseau JL; Attal M
N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
[No Abstract] [Full Text] [Related]
13. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
14. Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
Gul Z; Bashir Q; Cremer M; Yusuf SW; Gunaydin H; Arora S; Slone S; Nieto Y; Sherwani N; Parmar S; Shah N; Dinh YT; Hosing CM; Popat UR; Kebriaei P; Shpall EJ; Giralt SA; Champlin RE; Qazilbash MH
Leuk Lymphoma; 2015 Feb; 56(2):533-5. PubMed ID: 24882259
[No Abstract] [Full Text] [Related]
15. Melphalan-based autologous transplant in octogenarian multiple myeloma patients.
Saini NY; Patel R; Varma A; Bashir Q; Delgado R; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Weber DM; Thomas SK; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Champlin RE; Qazilbash MH
Am J Hematol; 2019 Jan; 94(1):E2-E5. PubMed ID: 30300461
[No Abstract] [Full Text] [Related]
16. [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
Krejcí M; Doubek M; Adam Z; Hájek R; Vorlícek J; Mayer J
Vnitr Lek; 1997 Nov; 43(11):756-8. PubMed ID: 9650509
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation].
Hájek R; Adam Z; Krejcí M; Vásová I; Král Z; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):278-84. PubMed ID: 8693716
[TBL] [Abstract][Full Text] [Related]
18. In focus: (166) Ho-DOTMP in the pretransplant treatment of multiple myeloma.
Clapp K
Clin Adv Hematol Oncol; 2004 Nov; 2(11):753-4. PubMed ID: 16170894
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoietic stem cell transplantation in multiple myeloma].
Vela-Ojeda J; Ruiz-Esparza MA
Rev Invest Clin; 2005; 57(2):305-13. PubMed ID: 16524072
[TBL] [Abstract][Full Text] [Related]
20. Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen.
Magagnoli M; Castagna L; Bramanti S; Balzarotti M; Santoro A
Bone Marrow Transplant; 2004 May; 33(10):1067-8. PubMed ID: 15129236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
